الصفحة الرئيسية>>Signaling Pathways>> Immunology/Inflammation>> Pulmonary Diseases>>Bis(methylthio)gliotoxin

Bis(methylthio)gliotoxin (Synonyms: Bisdethiobis(methylthio)gliotoxin, FR 49175)

رقم الكتالوجGC42941

يعتبر السم الجليوتوكسين ثنائي (ميثيلثيو) علامة أكثر استقرارًا وموثوقية لداء الرشاشيات الغازية من السم الجليوتوكسين ومناسب للاستخدام في التشخيص

Products are for research use only. Not for human use. We do not sell to patients.

Bis(methylthio)gliotoxin التركيب الكيميائي

Cas No.: 74149-38-5

الحجم السعر المخزون الكميّة
500μg
117٫00
متوفر
1mg
225٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Bis(methylthio)gliotoxin is a fungal metabolite originally isolated from G. deliquescens that has diverse biological activities. It inhibits PAF- and collagen-induced platelet aggregation in rabbit platelet-rich plasma (IC50s = 8.4 and 84.2 µM, respectively) but has no effect on arachidonic acid- or ADP-induced platelet aggregation (IC50s = >400 µM). Bis(methylthio)gliotoxin inhibits growth of HCT116 colon cancer cells (IC50 = 23.56 µM). It inhibits PAF-induced bronchoconstriction in guinea pigs when administered at a dose of 0.1 mg/kg and is less toxic to mice (LD50 = >500 mg/kg) than gliotoxin . Bis(methylthio)gliotoxin has been used as a serum biomarker in patients infected with invasive aspergillosis.

مراجعات

Review for Bis(methylthio)gliotoxin

Average Rating: 5 ★★★★★ (Based on Reviews and 26 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Bis(methylthio)gliotoxin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.